Navigation Links
Quantel Signs a Distribution Agreement With US-based National Biological
Date:10/14/2009

LES ULIS, France, October 14 /PRNewswire-FirstCall/ --

- National Biological to Market Quantel`s 308 Excimer System for Psoriasis and Vitiligo in the United States

Quantel SA (Euronext: QUA), a leading manufacturer of solid state lasers, announced today that it has entered into a Distribution Agreement with National Biological, a leading researcher and developer of light-based systems for medical and cosmetic treatments, for Quantel's 308 Excimer System for monochromatic UVB treatment of psoriasis and vitiligo in the United States.

Monochromatic UVB Therapy

The 308 Excimer System was developed by Quantel Derma, GmbH based in Erlangen, Germany. Its monochromatic light is equivalent to an excimer laser, with comparable clinical results. The 308 Excimer System is portable, efficient and has no consumables.

National Biological's Chief Executive Officer, Ken Oif commented, "The Quantel 308 targeted phototherapy System provides the best solution for the tens of thousands of patients who require localized treatment for psoriasis, vitiligo, and other skin diseases which are responsive to UV light. It is proven to be very effective and extremely easy to use. National Biological is very pleased to be able to provide Dermatologists with the best value of any targeted phototherapy system."

Exclusivity in the United States

The 308 Excimer System will be exclusively marketed by National Biological in the United States. National Biological will provide the Marketing, Sales, Clinical and Service support.

Alain de Salaberry, Quantel's Président Directeur Général said: "Its strong sales organization and its experience with UVB devices make National Biological an ideal partner for the marketing of Quantel's 308 Excimer System."

ABOUT THE QUANTEL Group

Founded in 1970, the QUANTEL Group has over the last 10 years established itself as one of the world's leading specialists for scientific (research laboratories, universities), industrial (micromachining, metrics, military) and medical (ophthalmology, dermatology) laser technologies.

ABOUT Nation Biological Corporation, Inc.

National Biological was founded in 1967 by a pharmacist who understood clearly that UV phototherapy provided a safer and more effective treatment than drugs for severe or chronic psoriasis, eczema, vitiligo and other skin conditions. Over the nearly 40 years since then, National Biological has become widely recognized among doctors and patients alike as the world leader in our field, consistently providing innovation, manufacture, and distribution of phototherapy equipment.

    Quantel is listed on NYSE Euronext (compartiment C) FR0000038242 - QUA
    http://www.quantel-laser.com

    Alain de SALABERRY
    Président Directeur Général
    T : +33-1-69-29-17-00
    info@quantel.fr

    Stefan SCHULZE
    CEO Quantel Derma GmbH
    T : +49-9131-9408810
    info@quantel-derma.com

    Mark Friedman
    President
    T : +1-216-831-0600
    Info@PhototherapyExperts.com

SOURCE QUANTEL


'/>"/>
SOURCE QUANTEL
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):